The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies such as machine learning, augmented reality, 5G and digitalization. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Environment Sustainability in Medical Devices: Bioabsorbable coated implants.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
150+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, robotic 3D bio-printing and 3D printed prosthesis are disruptive technologies that are in the early stages of application and should be tracked closely. Sharps disposal containers, biomedical 3D Printing, and tooth 3D Printing are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are bio-compatible surgical adjuncts and bio-active prosthesis sealing, which are now well established in the industry.
Innovation S-curve for environmental sustainability in the medical devices industry
Bioabsorbable coated implants is a key innovation area in environmental sustainability
Bioabsorbable coated implants are widely used in many fields, such as orthopaedics, cardiovascular and tissue engineering. They are non-permanent and eventually restore the biomechanical and immunological characteristics of the patient's tissue. They also act as a structural framework for healing and a pathway for further therapies, such as drug elution. They safely break down inside the body and do not require removal.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 130+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of bioabsorbable coated implants.
Key players in bioabsorbable coated implants – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to bioabsorbable coated implants
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|Medtronic||299||Unlock company profile|
|Stryker||205||Unlock company profile|
|Johnson & Johnson||201||Unlock company profile|
|Abbott Laboratories||201||Unlock company profile|
|EW Healthcare Partners||142||Unlock company profile|
|Micell Technologies||131||Unlock company profile|
|W. L. Gore & Associates||130||Unlock company profile|
|Cook Group||124||Unlock company profile|
|Terumo||96||Unlock company profile|
|Boston Scientific||86||Unlock company profile|
|Blue Sail Medical||75||Unlock company profile|
|Hellman & Friedman||72||Unlock company profile|
|Becton Dickinson and Co||58||Unlock company profile|
|MicroPort Scientific||57||Unlock company profile|
|Sernova||52||Unlock company profile|
|Medinol||46||Unlock company profile|
|AbbVie||40||Unlock company profile|
|OrbusNeich||38||Unlock company profile|
|Biotronik||37||Unlock company profile|
|MiMedx Group||36||Unlock company profile|
|Kona Gold Beverage||35||Unlock company profile|
|Getinge||35||Unlock company profile|
|Freudenberg||34||Unlock company profile|
|Merit Medical Systems||34||Unlock company profile|
|Concept Medical||32||Unlock company profile|
|Exogenesis||30||Unlock company profile|
|CorMatrix Cardiovascular||29||Unlock company profile|
|Royal DSM||29||Unlock company profile|
|Aveni||27||Unlock company profile|
|Zimmer Biomet Holdings||27||Unlock company profile|
|Otsuka Holdings||25||Unlock company profile|
|InspireMD||25||Unlock company profile|
|Japan Stent Technology||25||Unlock company profile|
|PolyPid||23||Unlock company profile|
|Children's Medical Center||23||Unlock company profile|
|Midcap Finco Designated Activity Company,||23||Unlock company profile|
|OrbusNeich Medical||23||Unlock company profile|
|Straumann Holding||22||Unlock company profile|
|Orthorebirth||21||Unlock company profile|
|Reflow Medical||21||Unlock company profile|
|Q3 Medical Devices||21||Unlock company profile|
|LifeTech Scientific||21||Unlock company profile|
|Biotyx Medical (Shenzhen)||19||Unlock company profile|
|B. Braun Melsungen||19||Unlock company profile|
|BioNet Holding||19||Unlock company profile|
|Elixir Medical||19||Unlock company profile|
|Massachusetts General Hospital||18||Unlock company profile|
|Itochu||18||Unlock company profile|
|General Hospital||17||Unlock company profile|
|Galilee Medical Center||17||Unlock company profile|
Source: GlobalData Patent Analytics
In terms of application diversity, Orthorebirth leads the pack, followed by Aveni and PolyPid. By means of geographic reach, Sernova holds the top position, followed by PolyPid and Orthorebirth in the second and third spots respectively.
Bioabsorbable implants are gaining popularity due to their crucial role in tissue rebuilding following the intended function in the body. Based on the function that the material performs in the body, they decay at a pace that is acceptable and necessary to the body. Future development should focus on improving the biomechanical properties of bioabsorbable implants.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.